Abstract:
A female patient, 43, non-diabetic, non-hypertensive experienced RE-sudden loss of vision in
May 2016. Her vision at that time was found to be RE-counting ngers, LE-6/5p, near vision
with presbiopic correction +1.50D for RE-N36p, LE-N6. On examination, the patient was
diagnosed as RE-Central retinal arterial occlusion with cherry red macular hemorrhage and
retinal oedema. She was referred to vitreoretinal surgeon and on his recommendation, she was
given LASER treatment after 2 days. She also underwent intravitreal [IV] injectables twice to
reduce retinal oedema. With this treatment, her vision was improved to 6/12p, N10. But she had
RE-oaters in vision as a new symptom; on examination RE fundus showed macular oedema
and epiretinal membrane [ERM] involving partial macular area. The patient underwent OCT to
determine severity of macular oedema and other structural pathology. As there was limited relief
with IV injectables, she was advised to take Ayurvedic treatment for further improvement in
vision and to get rid of other symptoms as an alternative and complementary treatment. The
patient was advised only systemic Ayurvedic Shaman treatment and no local treatment was
given. She was advised to take Ayurvedic medicines which included Chandraprabha Vati
250mg 2 tabs twice a day, Manjisthadi Vati 750mg 1 tab twice a day, Nimbamrutadi Vati 750mg 1
tab in the morning and 2 tabs at bed time, Amalaki Ghana Vati 250mg 1tab in the morning and 2
tabs at bed time, Gomootra Haritaki 150mg 2 tabs twice a day (All tabs with lukewarm water as
Anupana) and Timir Ghrita 10ml bed time with lukewarm milk. This treatment continued from
October 2016 to April 2017. With this treatment, her vision improved to 6/6p, N8 in March
2017.She was advised to continue same medicines along with addition of tab Vasanta
Kusumakar 40mg at bed time and tab Yashtimadhu Ghana 250mg twice a day. Follow up was
done in April 2017, where she had vision in RE 6/6, N6. Her fundus showed regression of ERM
with decrease in macular oedema which was conrmed on OCT.